Last updated: August 5, 2020
Sponsor: Baycrest
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mild Cognitive Impairment
Dementia
Mental Disability
Treatment
N/AClinical Study ID
NCT04503798
#08-53
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of nonamnestic mild cognitive impairment
Available to participate in all testing and intervention sessions
Access to a computer
Computer familiarity
Normal or corrected-to-normal vision and hearing
Exclusion
Exclusion Criteria:
Diagnosis of amnestic mild cognitive impairment or dementia
Moderate to severe affective impairment defined by score above cut-off for depressionon the Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001)
Study Design
Total Participants: 50
Study Start date:
August 20, 2020
Estimated Completion Date:
December 30, 2021
Connect with a study center
Baycrest Health Sciences
Toronto, Ontario M6A2E1
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.